Literature DB >> 23775343

Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3.

Tátila Martins Lopes1, Anelyssa D'Abreu, Marcondes Cavalcante França, Clarissa Lin Yasuda, Luiz Eduardo Betting, Adriana Bastos Samara, Gabriela Castellano, Júlio César Somazz, Marcio Luiz Figueredo Balthazar, Iscia Lopes-Cendes, Fernando Cendes.   

Abstract

Previous studies demonstrated cognitive impairments in spinocerebellar ataxia type 3 (SCA3/MJD); however, there is no consensus about the cognitive domains affected and the correlation with structural brain abnormalities. We investigated the neuropsychological profile and 3T-MRI findings, including high-resolution T1-images, diffusion tensor imaging and magnetic resonance spectroscopy of 32 patients with SCA3/MJD and 32 age-, gender- and educational level-matched healthy controls. We reviewed patients' clinical history and CAG repeat length, and performed assessment and rating of ataxia (SARA)-Brazilian version and the neuropsychiatric inventory. Patients presented worse performance in episodic and working memory and Beck inventories (depression and anxiety). SCA3/MJD patients had a reduction of gray matter volume (GM) in the cerebellum, putamen, cingulum, precentral and parietal lobe. A positive correlation was identified between the cognitive findings and GM of temporal, frontal, parietal, culmen and insula. We observed positive correlation between the brainstem's fractional anisotropy and digit span-forward. The following cerebellar metabolite groups (measured relative to creatine) were reduced in patients: N-acetyl-aspartate (NAA), NAA + N-acetyl-aspartate-glutamate and glutamate + glutamine (Glx). We found a positive correlation between Corsi's block-tapping task forward with Glx; semantic verbal fluency with phosphorylcholine and glycerophosphorylcholine; digits span-forward with NAA. The cognitive impairments in SCA3/MJD are associated not only with cerebellar and brainstem abnormalities, but also with neuroimaging evidence of diffuse neuronal and axonal dysfunction, particularly in temporal, frontal, parietal and insular areas.

Entities:  

Mesh:

Year:  2013        PMID: 23775343     DOI: 10.1007/s00415-013-6998-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  33 in total

1.  Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder.

Authors:  Thomas Ernst; Caroline S Jiang; Helenna Nakama; Steven Buchthal; Linda Chang
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

2.  Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults.

Authors:  Kejal Kantarci; V Lowe; S A Przybelski; M L Senjem; S D Weigand; R J Ivnik; R Roberts; Y E Geda; B F Boeve; D S Knopman; R C Petersen; C R Jack
Journal:  Neurology       Date:  2011-08-24       Impact factor: 9.910

3.  Magnetic resonance imaging findings of Machado-Joseph disease: histopathologic correlation.

Authors:  Aya M Tokumaru; Keiko Kamakura; Toshiyuki Maki; Shigeo Murayama; Ikuko Sakata; Tatsumi Kaji; Shinnya Kohyama; Shoichi Kusano; Seiji Hasegawa
Journal:  J Comput Assist Tomogr       Date:  2003 Mar-Apr       Impact factor: 1.826

4.  Characteristic magnetic resonance imaging findings in Machado-Joseph disease.

Authors:  Y Murata; S Yamaguchi; H Kawakami; Y Imon; H Maruyama; T Sakai; T Kazuta; T Ohtake; M Nishimura; T Saida; S Chiba; T Oh-i; S Nakamura
Journal:  Arch Neurol       Date:  1998-01

5.  Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study.

Authors:  Anelyssa D'Abreu; Marcondes C França; Clarissa L Yasuda; Bruno A G Campos; Iscia Lopes-Cendes; Fernando Cendes
Journal:  J Neuroimaging       Date:  2011-06-23       Impact factor: 2.486

6.  Machado-Joseph disease of Azorean ancestry in Brazil: the Catarina kindred. Neurological, neuroimaging, psychiatric and neuropsychological findings in the largest known family, the "Catarina" kindred.

Authors:  J Radvany; C H Camargo; Z M Costa; N C Fonseca; E D Nascimento
Journal:  Arq Neuropsiquiatr       Date:  1993-03       Impact factor: 1.420

7.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

8.  Validation of the Brazilian Children's Test of Pseudoword Repetition in Portuguese speakers aged 4 to 10 years.

Authors:  F H Santos; O F A Bueno
Journal:  Braz J Med Biol Res       Date:  2003-10-22       Impact factor: 2.590

9.  Executive and emotional dysfunction in Machado-Joseph disease.

Authors:  Tricia M Zawacki; Janet Grace; Joseph H Friedman; Lewis Sudarsky
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338

10.  Cognitive deficits in Machado-Joseph disease.

Authors:  P Maruff; P Tyler; T Burt; B Currie; C Burns; J Currie
Journal:  Ann Neurol       Date:  1996-09       Impact factor: 10.422

View more
  28 in total

1.  Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency.

Authors:  Sarah Doss; Jan Leo Rinnenthal; Tanja Schmitz-Hübsch; Alexander U Brandt; Sebastian Papazoglou; Silke Lux; Stephan Maul; Jens Würfel; Matthias Endres; Thomas Klockgether; Martina Minnerop; Friedemann Paul
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

2.  Cognition in SCA21 reflects developmental and adult onset cerebellar cognitive affective syndrome.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Orlando G P Barsottini; Jeremy D Schmahmann
Journal:  Brain       Date:  2015-01-08       Impact factor: 13.501

3.  Psychosis in Machado-Joseph Disease: Clinical Correlates, Pathophysiological Discussion, and Functional Brain Imaging. Expanding the Cerebellar Cognitive Affective Syndrome.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Ary Gadelha; Maura Regina Laureano; Cristiano de Souza Noto; Griselda Jara Garrido; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2016-08       Impact factor: 3.847

Review 4.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

5.  Selective Procedural Memory Impairment but Preserved Declarative Memory in Spinocerebellar Ataxia Type 3.

Authors:  Zohar Elyoseph; Matti Mintz; Eli Vakil; Roy Zaltzman; Carlos R Gordon
Journal:  Cerebellum       Date:  2020-04       Impact factor: 3.847

6.  MR Imaging in Spinocerebellar Ataxias: A Systematic Review.

Authors:  A Klaes; E Reckziegel; M C Franca; T J R Rezende; L M Vedolin; L B Jardim; J A Saute
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-12       Impact factor: 3.825

7.  Structural signature in SCA1: clinical correlates, determinants and natural history.

Authors:  Carlos Roberto Martins Junior; Alberto Rolim Muro Martinez; Ingrid Faber Vasconcelos; Thiago Junqueira Ribeiro de Rezende; Raphael Fernandes Casseb; Jose Luiz Pedroso; Orlando Graziani Povoas Barsottini; Íscia Lopes-Cendes; Marcondes Cavalcante França
Journal:  J Neurol       Date:  2018-10-15       Impact factor: 4.849

8.  Spinal cord damage in Machado-Joseph disease.

Authors:  Camila N Fahl; Lucas Melo T Branco; Felipe P G Bergo; Anelyssa D'Abreu; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

9.  Executive dysfunction in patients with spinocerebellar ataxia type 3.

Authors:  Itaru Tamura; Asako Takei; Shinsuke Hamada; Hiroyuki Soma; Michio Nonaka; Sanae Homma; Fumio Moriwaka
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

10.  Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.

Authors:  Biswarathan Ramani; Bharat Panwar; Lauren R Moore; Bo Wang; Rogerio Huang; Yuanfang Guan; Henry L Paulson
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.